RTX enters the week with a mild negative bias — down 2.6% over five sessions to $174.26 — even as analysts remain broadly bullish and the lending market signals no meaningful bear conviction.
The options picture offers a mild note of caution. The put/call ratio has climbed to 0.726, running above its 20-day average of 0.687 and roughly one standard deviation higher. That's not an alarm — it's still well below the 52-week high of 0.91 set earlier in the year — but the drift upward over the past two weeks does suggest incremental hedging demand is building as the stock slides. Context matters: in late April, when the PCR was closer to 0.82, RTX sold off sharply on earnings. The current reading is a more subdued version of that defensive tilt.
Short interest tells a far less aggressive story. At just 1.2% of the free float, it remains structurally low and not a meaningful trading signal on its own. Short shares did tick up roughly 4% in a single session on June 2, and the monthly trend shows an 18% increase from early May levels — but the absolute level is still negligible. Borrow costs confirm the same message: cost-to-borrow runs at just 0.22% annually, and availability is effectively uncapped, with lendable shares far exceeding what's currently borrowed. There is no squeeze dynamic here. Bears who want to express a view face no friction at all in the lending market.
The Street remains constructive, though the enthusiasm has moderated. The consensus mean price target is $215.27, implying roughly 23% upside from current levels — an unusually wide gap that earns RTX a 92nd-percentile rank on analyst return potential. The most recent analyst moves, clustered around the April earnings print, were uniformly target cuts: Morgan Stanley trimmed from $235 to $220 while keeping Overweight, UBS dropped from $209 to $199 at Neutral, and Jefferies held Hold at $210 versus $225 prior. That pattern — cuts, but no downgrades — is the Street's way of acknowledging near-term turbulence while maintaining the longer-term thesis. No firm has changed its rating direction since January. The dividend score ranks in the 95th percentile, reflecting RTX's consistent capital return track record, though the available dividend history in the data is stale and shouldn't be quoted directly.
The April 21 earnings reaction is worth remembering as Q3 approaches. RTX fell 7.6% the day of its Q1 2026 results and dropped a further 10.3% over the following five sessions — one of the sharpest single-quarter selloffs in recent memory for this name. The bull case centered on Pratt & Whitney's commercial aftermarket strength, with 19% growth in GTF and V2500 engine sales. The bear case flagged a $1 million loss on each new GTF engine delivery alongside slower-than-expected recovery in commercial aerospace. The stock has since recouped some of that ground, but the gap between the current price and analyst targets is, in part, a reflection of how far it fell. The next earnings date is July 21.
Peer performance this week reinforces that the weakness is sector-wide rather than RTX-specific. NOC fell 3.6% and LMT dropped 3.7% — both tighter than RTX's own decline. HII underperformed sharply, down more than 8%. DRS and LOAR bucked the trend, each posting modest weekly gains. The divergence within the defense complex is worth monitoring: names with higher commercial aerospace exposure have lagged, while pure-play defense contractors with fewer supply-chain headwinds have held up better.
The note to watch heading into July 21 is straightforward: whether management's commentary on GTF engine profitability trajectory and commercial aerospace recovery pace is sufficient to close the gap between where the stock trades and where analysts think it belongs.
See the live data behind this article on ORTEX.
Open RTX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
